Theraclion Statistics

Total Valuation

Theraclion has a market cap or net worth of EUR 36.55 million. The enterprise value is 44.41 million.

Market Cap	36.55M
Enterprise Value	44.41M

Important Dates

The last earnings date was Thursday, April 16, 2026.

Earnings Date	Apr 16, 2026
Ex-Dividend Date	n/a

Share Statistics

Theraclion has 73.11 million shares outstanding. The number of shares has increased by 29.27% in one year.

Current Share Class	73.11M
Shares Outstanding	73.11M
Shares Change (YoY)	+29.27%
Shares Change (QoQ)	n/a
Owned by Insiders (%)	26.42%
Owned by Institutions (%)	3.89%
Float	39.54M

Valuation Ratios

PE Ratio	n/a
Forward PE	n/a
PS Ratio	56.06
PB Ratio	-14.12
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Financial Ratio History

Enterprise Valuation

EV / Earnings	-7.80
EV / Sales	68.11
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 2.79

Current Ratio	2.79
Quick Ratio	1.85
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-47.81

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-40.38%
Return on Invested Capital (ROIC)	-59.68%
Return on Capital Employed (ROCE)	-84.38%
Weighted Average Cost of Capital (WACC)	4.60%
Revenue Per Employee	18,111
Profits Per Employee	-158,056
Employee Count	36
Asset Turnover	0.05
Inventory Turnover	1.59

Taxes

Income Tax	-837,000
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has increased by +66.50% in the last 52 weeks. The beta is 0.26, so Theraclion's price volatility has been lower than the market average.

Beta (5Y)	0.26
52-Week Price Change	+66.50%
50-Day Moving Average	0.50
200-Day Moving Average	0.63
Relative Strength Index (RSI)	46.46
Average Volume (20 Days)	184,892

Short Selling Information

Short Interest	n/a
Short Previous Month	n/a
Short % of Shares Out	n/a
Short % of Float	n/a
Short Ratio (days to cover)	n/a

Income Statement

In the last 12 months, Theraclion had revenue of EUR 652,000 and -5.69 million in losses. Loss per share was -0.10.

Revenue	652,000
Gross Profit	-3.07M
Operating Income	-7.75M
Pretax Income	-6.53M
Net Income	-5.69M
EBITDA	-7.35M
EBIT	-7.75M
Loss Per Share	-0.10

Full Income Statement

Balance Sheet

The company has 3.38 million in cash and 11.23 million in debt, with a net cash position of -7.85 million or -0.11 per share.

Cash & Cash Equivalents	3.38M
Total Debt	11.23M
Net Cash	-7.85M
Net Cash Per Share	-0.11
Equity (Book Value)	-2.59M
Book Value Per Share	-0.04
Working Capital	5.97M

Full Balance Sheet

Cash Flow

Operating Cash Flow	-7.16M
Capital Expenditures	n/a
Depreciation & Amortization	399,000
Net Borrowing	n/a
Free Cash Flow	n/a
FCF Per Share	n/a

Full Cash Flow Statement

Margins

Gross Margin	n/a
Operating Margin	-1,188.04%
Pretax Margin	-1,001.07%
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

Theraclion does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-29.27%
Shareholder Yield	-29.27%
Earnings Yield	-15.57%
FCF Yield	n/a

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

This stock does not have any record of stock splits.

Last Split Date	n/a
Split Type	n/a
Split Ratio	n/a

Scores

Theraclion has an Altman Z-Score of -1.5. A Z-score under 3 suggests an increased risk of bankruptcy.

Altman Z-Score	-1.5
Piotroski F-Score	n/a